Uncategorized
Glaukos Announces 2017 Investor Day and Webcast
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced that it will host an Investor Day in New York City on Thursday, September 14, 2017, beginning at 8 a.m. EDT and concluding at approximately 11:30 a.m. EDT. The meeting will include remarks from members of the Glaukos executive team